Bessemer Group Inc Eli Lilly & CO Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Bessemer Group Inc holds 315,252 shares of LLY stock, worth $251 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

315,252

Previous 308,056 2.34%

Holding current value

$251 Million

Previous $279 Million 0.14%

% of portfolio

0.46%

Previous 0.49%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $5.56 Million - $6.91 Million	7,196 Added 2.34%	315,252 $279 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $13.6 Million - $17.1 Million	18,828 Added 6.51%	308,056 $279 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $7.05 Million - $9.44 Million	-11,912 Reduced 3.96%	289,228 $225 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $12.3 Million - $14.6 Million	23,511 Added 8.47%	301,140 $176 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $93.6 Million - $129 Million	215,315 Added 345.53%	277,629 $149 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $1.86 Million - $2.49 Million	5,299 Added 9.29%	62,314 $29.2 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $410,963 - $482,656	1,323 Added 2.38%	57,015 $19.6 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $586,828 - $683,772	1,825 Added 3.39%	55,692 $20.4 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $3.82 Million - $4.35 Million	12,888 Added 31.45%	53,867 $17.4 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $279,566 - $328,251	-1,003 Reduced 2.39%	40,979 $13.3 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $1.44 Million - $1.8 Million	6,157 Added 17.19%	41,982 $12 Million
Q4 2021 Jan 27, 2022	BUY	$224.85 - $279.04 $1.9 Million - $2.36 Million	8,448 Added 30.86%	35,825 $9.9 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $189,468 - $233,167	855 Added 3.22%	27,377 $6.33 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $338,170 - $437,420	1,873 Added 7.6%	26,522 $6.09 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $386,644 - $500,530	-2,353 Reduced 8.71%	24,649 $4.6 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $8.61 Million - $11.4 Million	-65,964 Reduced 70.95%	27,002 $4.56 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $41 Million - $47.4 Million	-280,132 Reduced 75.08%	92,966 $13.8 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $2.3 Million - $2.77 Million	16,848 Added 4.73%	373,098 $61.3 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $25.2 Million - $31.2 Million	-211,931 Reduced 37.3%	356,250 $49.4 Million
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $367,590 - $455,294	-3,438 Reduced 0.6%	568,181 $74.7 Million
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $225,220 - $244,981	2,109 Added 0.37%	571,619 $63.9 Million
Q2 2019 Jul 19, 2019	BUY	$110.79 - $129.32 $60.5 Million - $70.6 Million	546,307 Added 2354.47%	569,510 $63.1 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $161,399 - $189,979	-1,450 Reduced 5.88%	23,203 $3.01 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $41,618 - $46,625	393 Added 1.62%	24,653 $2.85 Million
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $119,602 - $149,482	-1,393 Reduced 5.43%	24,260 $2.6 Million
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $726,190 - $833,439	-9,593 Reduced 27.22%	25,653 $2.19 Million
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $232 Million - $274 Million	-3,132,885 Reduced 98.89%	35,246 $2.73 Million
Q4 2017 Jan 30, 2018	SELL	$81.94 - $87.89 $735,411 - $788,812	-8,975 Reduced 0.28%	3,168,131 $268 Million
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $245 Million - $272 Million	3,177,106	3,177,106 $272 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Eli Lilly & CO Transaction History